ST, H., R, M., M, H., C, B., & MB, M. (2023). Enabling CAR T-cell therapies for HIV-positive lymphoma patients - A call for action. HIV medicine, 24(9), 957. https://doi.org/10.1111/hiv.13514
Chicago Style (17th ed.) CitationST, Hattenhauer, Mispelbaum R, Hentrich M, Boesecke C, and Monin MB. "Enabling CAR T-cell Therapies for HIV-positive Lymphoma Patients - A Call for Action." HIV Medicine 24, no. 9 (2023): 957. https://doi.org/10.1111/hiv.13514.
MLA (9th ed.) CitationST, Hattenhauer, et al. "Enabling CAR T-cell Therapies for HIV-positive Lymphoma Patients - A Call for Action." HIV Medicine, vol. 24, no. 9, 2023, p. 957, https://doi.org/10.1111/hiv.13514.
Warning: These citations may not always be 100% accurate.